Msp Lab Instruments Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
- Revenue Growth %
- Profit Growth 730.90%
- Ebitda 2029.24%
- Net Worth 22.84%
- Total Assets 763.38%
About Msp Lab Instruments
Msp Lab Instruments Private Limited (MLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 January 2021 (Four years and one month 18 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.50 Cr.
Shyam Mavuluri and Mavuluri Sudha serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52590TG2021PTC147500
- Company No.
147500
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Msp Lab Instruments?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shyam Mavuluri  | Director | 07-Jan-2021 | Current |
| Mavuluri Sudha | Director | 07-Jan-2021 | Current |
Financial Performance of Msp Lab Instruments.
Msp Lab Instruments Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 730.9% increase in profit. The company's net worth Soared by an impressive increase of 22.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Msp Lab Instruments?
Unlock access to Msp Lab Instruments's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prk Pharmanlysts Private LimitedShyam Mavuluri and Mavuluri Sudha are mutual person
Charges (Loans)
₹25.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2023 | Axis Bank Limited | ₹2.50 Cr | Open |
How Many Employees Work at Msp Lab Instruments?
Unlock and access historical data on people associated with Msp Lab Instruments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Msp Lab Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Msp Lab Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.